X-57592270-G-C

Variant summary

Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2

The NM_007157.4(ZXDB):​c.222G>C​(p.Leu74Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000568 in 1,172,386 control chromosomes in the GnomAD database, including 2 homozygotes. There are 294 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.00048 ( 0 hom., 9 hem., cov: 23)
Exomes š‘“: 0.00058 ( 2 hom. 285 hem. )

Consequence

ZXDB
NM_007157.4 missense

Scores

2
2
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: 2.17
Variant links:
Genes affected
ZXDB (HGNC:13199): (zinc finger X-linked duplicated B) The ZXDB gene is one of a pair of duplicated zinc finger genes on chromosome Xp11.21 (Greig et al., 1993 [PubMed 8268913]); see also ZXDA (MIM 300235).[supplied by OMIM, Jul 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -7 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0711042).
BP6
Variant X-57592270-G-C is Benign according to our data. Variant chrX-57592270-G-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 2345194.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=1}.
BS2
High Hemizygotes in GnomAd4 at 9 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ZXDBNM_007157.4 linkc.222G>C p.Leu74Phe missense_variant Exon 1 of 1 ENST00000374888.3 NP_009088.1 P98169

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ZXDBENST00000374888.3 linkc.222G>C p.Leu74Phe missense_variant Exon 1 of 1 6 NM_007157.4 ENSP00000364023.1 P98169

Frequencies

GnomAD3 genomes
AF:
0.000480
AC:
53
AN:
110439
Hom.:
0
Cov.:
23
AF XY:
0.000270
AC XY:
9
AN XY:
33389
show subpopulations
Gnomad AFR
AF:
0.000526
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000570
Gnomad ASJ
AF:
0.000386
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000744
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00441
Gnomad NFE
AF:
0.000515
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000372
AC:
45
AN:
120835
Hom.:
0
AF XY:
0.000386
AC XY:
14
AN XY:
36305
show subpopulations
Gnomad AFR exome
AF:
0.000554
Gnomad AMR exome
AF:
0.000175
Gnomad ASJ exome
AF:
0.000172
Gnomad EAS exome
AF:
0.000115
Gnomad SAS exome
AF:
0.00103
Gnomad FIN exome
AF:
0.000104
Gnomad NFE exome
AF:
0.000392
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000577
AC:
613
AN:
1061904
Hom.:
2
Cov.:
31
AF XY:
0.000824
AC XY:
285
AN XY:
346036
show subpopulations
Gnomad4 AFR exome
AF:
0.000645
Gnomad4 AMR exome
AF:
0.000245
Gnomad4 ASJ exome
AF:
0.00258
Gnomad4 EAS exome
AF:
0.000222
Gnomad4 SAS exome
AF:
0.00149
Gnomad4 FIN exome
AF:
0.000210
Gnomad4 NFE exome
AF:
0.000514
Gnomad4 OTH exome
AF:
0.000584
GnomAD4 genome
AF:
0.000480
AC:
53
AN:
110482
Hom.:
0
Cov.:
23
AF XY:
0.000269
AC XY:
9
AN XY:
33442
show subpopulations
Gnomad4 AFR
AF:
0.000525
Gnomad4 AMR
AF:
0.000569
Gnomad4 ASJ
AF:
0.000386
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000746
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000515
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000369
Hom.:
3
ExAC
AF:
0.000529
AC:
59

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1
May 14, 2024
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.222G>C (p.L74F) alteration is located in exon 1 (coding exon 1) of the ZXDB gene. This alteration results from a G to C substitution at nucleotide position 222, causing the leucine (L) at amino acid position 74 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

not provided Benign:1
Feb 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

ZXDB: BS2 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.085
BayesDel_addAF
Benign
-0.30
T
BayesDel_noAF
Benign
-0.67
CADD
Benign
18
DANN
Uncertain
0.98
DEOGEN2
Benign
0.012
T
FATHMM_MKL
Benign
0.60
D
LIST_S2
Benign
0.40
T
M_CAP
Pathogenic
0.54
D
MetaRNN
Benign
0.071
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.3
M
PrimateAI
Pathogenic
0.84
D
PROVEAN
Benign
-0.11
N
REVEL
Benign
0.079
Sift
Benign
0.20
T
Sift4G
Benign
0.19
T
Polyphen
0.97
D
Vest4
0.021
MutPred
0.17
Gain of glycosylation at S72 (P = 0.1381);
MVP
0.26
MPC
1.6
ClinPred
0.029
T
GERP RS
2.4
Varity_R
0.091
gMVP
0.041

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs768201846; hg19: chrX-57618703; COSMIC: COSV66492865; API